BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12048517)

  • 41. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Descriptive study on basal cell eyelid carcinoma].
    Pfeiffer MJ; Pfeiffer N; Valor C
    Arch Soc Esp Oftalmol; 2015 Sep; 90(9):426-31. PubMed ID: 25817947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
    Anthouli-Anagnostopoulou F; Hatziolou E
    Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal cell carcinoma in the head and neck. The importance of location and histological picture, studied with a new scoring system, in predicting recurrences.
    Afzelius LE; Ehnhage A; Nordgren H
    Acta Pathol Microbiol Scand A; 1980 Jan; 88(1):5-9. PubMed ID: 7376876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Punch biopsy in the management of periocular basal cell carcinomas.
    Chatterjee S; Moore S; Kumar B
    Orbit; 2004 Jun; 23(2):87-92. PubMed ID: 15545121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Basalioma of the eyelid: rate and factors of recurrence after surgical therapy].
    Svetlosáková Z; Halás M; Krásnik V; Strmen P
    Cesk Slov Oftalmol; 2010 Oct; 66(4):171-5. PubMed ID: 21394970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Large basal cell carcinoma of the external palpebral angle].
    D'Hermies F; Morel X; Meyer A; Cohen FB; Halhal M; Vu TA; Elmaleh C; Renard G
    J Fr Ophtalmol; 2001 Dec; 24(10):1117-9. PubMed ID: 11913246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An assessment of incomplete facial Basal cell carcinoma excision.
    Shah SA; Obaidullah ; Fahimullah
    J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of development of basal versus squamous cell carcinoma.
    Shemesh S; Spencer JM; Phelps RG
    J Drugs Dermatol; 2006 Jan; 5(1):40-4. PubMed ID: 16468291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indications and results of cryotherapy of eyelid tumors].
    Prskavec FH
    Wien Klin Wochenschr; 1986 May; 98(9):279-81. PubMed ID: 3727599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The adequacy of the surgical excision of basal cell carcinoma.
    Rakofsky SI
    Ann Ophthalmol; 1973 May; 5(5):596-600. PubMed ID: 4709102
    [No Abstract]   [Full Text] [Related]  

  • 56. Basal cell carcinoma of the eyelid in children: a report of three cases.
    Al-Buloushi A; Filho JP; Cassie A; Arthurs B; Burnier MN
    Eye (Lond); 2005 Dec; 19(12):1313-4. PubMed ID: 15650761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clear-cell basal cell carcinoma of the upper eyelid: a case report.
    Morioka D; Kinoshita Y; Tanabe T; Ueda Y
    Ann Plast Surg; 1999 Aug; 43(2):215-7. PubMed ID: 10454334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
    Soysal HG; Soysal E; Markoç F; Ardiç F
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
    Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
    Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.